Alchemab Therapeutics
Alchemab Therapeutics42
About
What does Alchemab Therapeutics do?
Alchemab Therapeutics is a clinical-stage biotechnology startup founded in 2019. The company focuses on discovering and developing novel antibody therapeutics by identifying naturally occurring protective antibodies from individuals who are resilient to specific diseases. They utilize well-defined patient samples, deep B cell sequencing, and computational analysis to identify convergent protective antibody responses. These identified antibodies are then developed into therapeutic products for ha…
What is Alchemab Therapeutics's revenue?
StartupHub estimates Alchemab Therapeutics's annual revenue at $3.9M (range $1.1M to $11.8M, 34% confidence), based on comparable companies in the sector.
What is Alchemab Therapeutics's valuation?
StartupHub estimates Alchemab Therapeutics's effective valuation at $121.0M (range $78.8M to $189.0M, 24% confidence), based on comparable companies in the sector.
How much funding has Alchemab Therapeutics raised?
Alchemab Therapeutics has raised a total of $32M in funding. The most recent round on record is Series A.
Where is Alchemab Therapeutics headquartered?
Alchemab Therapeutics is headquartered in London, England, United Kingdom.
When was Alchemab Therapeutics founded?
Alchemab Therapeutics was founded in 2019.
What industry does Alchemab Therapeutics operate in?
Alchemab Therapeutics operates in Biotechnology, Pharmaceuticals, Artificial Intelligence, Drug Discovery, Biotech, Clinical Trials.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Scan this site yourselfStrength of the site’s backlink profile, on the industry-standard 0-100 scale. Licensed third-party data, not our opinion.
Check any domain freeStar ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.
No comments yet. Be the first to share your take.